Interstitial Cystitis Clinical Trials 2024

Interstitial Cystitis Clinical Trials 2024

Interstitial Cystitis research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in interstitial cystitis clinical trials today.

Interstitial Cystitis Clinical Trials

Here are the 6 most popular medical studies for interstitial cystitis

Popular filter options for interstitial cystitis trials

IC Clinical Trials

View 19 IC medical studies.

Interstitial Cystitis Clinical Trials With No Placebo

View 20 interstitial cystitis medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to interstitial cystitis

What are the top hospitals conducting interstitial cystitis research?

When it comes to the treatment and research of interstitial cystitis, several hospitals are leading the way in advancing our understanding and finding potential solutions for this challenging condition. In Winston-Salem, North carolina, Wake Forest University Health Sciences is at the forefront with three active interstitial cystitis trials and a total of four conducted trials since their first recorded investigation in 2015. Meanwhile, William Beaumont Hospital in Royal Oak, Michigan has been dedicated to studying this condition since 2004 and currently has two ongoing clinical trials along with an impressive history of 19 completed studies.

In Philadelphia, the Pelvic and Sexual Health Institute is making strides with two active interstitial cystitis trials. Although they have conducted only three previous investigations since recording their first trial in 2007, their commitment to understanding this complex disorder remains unwavering.

Closer to home for those residing in Winston-Salem is Atrium Health Wake Forest Baptist Health. While still relatively new to conducting clinical trials on interstitial cystitis with just one active trial at present, their determination shines through as they recorded their first-ever trial for this condition scheduled for 2023.

Lastly but certainly not least, Urology Centers of Alabama (ID#243600) located in Homewood contributes significantly by actively engaging themselves into one current trial related to Interstitial Cystitis while having accomplished a single study previously from its initiation backdated until2022; these small-scale efforts signify valuable contributions towards solving mysteries surrounding this chronic bladder disorder that affects countless individuals worldwide.

These hospitals exemplify dedication and innovation when it comes to researching treatments for interstitial cystitis. The collaborative efforts between medical professionals at these institutions give hope that improved options will be available soon for those suffering from this often debilitating condition

Which are the best cities for interstitial cystitis clinical trials?

When it comes to interstitial cystitis clinical trials, several cities emerge as leaders in research. Los Angeles, California has 11 active trials investigating treatments like AQX-1125 100 mg and IW-3300 300 µg among others. Winston-Salem, North carolina follows closely behind with nine ongoing studies focusing on interventions such as Pulsed Electromagnetic Field treatment with intravesical bupivacaine/heparin instillations and Auricular Acupressure (AA). San Diego, California also contributes significantly with seven active trials exploring options like Lidocaine and BOTOX. These cities offer individuals living with interstitial cystitis access to cutting-edge clinical trials that pave the way for advancements in care and improved quality of life.

Which are the top treatments for interstitial cystitis being explored in clinical trials?

Clinical trials are shedding light on promising treatments for interstitial cystitis, a condition that causes chronic bladder pain. Here are the leading contenders currently being explored:

  • Botox: With several ongoing trials, Botox injections show potential in managing interstitial cystitis symptoms.
  • Cyclosporine: This immunosuppressive drug is undergoing clinical investigation and may offer relief to patients battling this debilitating condition.
  • PPS (Pentosan Polysulfate Sodium): Multiple trials are examining the efficacy of PPS in alleviating the symptoms of interstitial cystitis.

As researchers delve deeper into these treatment options through clinical trials, hope continues to grow for individuals suffering from interstitial cystitis.

What are the most recent clinical trials for interstitial cystitis?

Recent clinical trials offer hope for individuals suffering from interstitial cystitis, a chronic condition that affects the bladder. Among these trials is Lidocaine, which has entered Phase 2 testing and shows potential as a treatment option. Another promising candidate is IW-3300 at a dosage of 300 µg, also in Phase 2 development. Additionally, a Phase 3 trial focusing on multimodal care bundles aims to provide comprehensive management strategies for interstitial cystitis patients. While BOTOX has completed its Phase 2 testing phase and showed promise in addressing symptoms associated with this condition, peppermint oil is undergoing both Phase 1 and Phase 2 studies. These recent developments bring new possibilities for improved quality of life among those affected by interstitial cystitis.

What interstitial cystitis clinical trials were recently completed?

A recent clinical trial investigating the efficacy of low-dose naltrexone in treating interstitial cystitis has concluded. Sponsored by NorthShore University HealthSystem, the trial was completed in September 2021. This study represents a significant step forward in understanding and potentially improving treatment options for individuals with interstitial cystitis, a chronic condition characterized by bladder pain and discomfort.